<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2017.00022</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>p75 Neurotrophin Receptor in the Skin: Beyond Its Neurotrophic Function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Pincelli</surname> <given-names>Carlo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/363198"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratory of Cutaneous Biology, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia</institution>, <addr-line>Modena</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Alexander A. Navarini, University of Zurich, Switzerland</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: J&#x000E9;r&#x000F4;me Lamartine, University of Lyon, France; Michel Simon, Inserm, France</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Carlo Pincelli, <email>carlo.pincelli&#x00040;unimore.it</email></corresp>
<fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Dermatology, a section of the journal Frontiers in Medicine</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>03</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>4</volume>
<elocation-id>22</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>02</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Pincelli.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Pincelli</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>p75 neurotrophin receptor (p75<sup>NTR</sup>), also known as CD271, is the low-affinity receptor that, together with the tyrosine kinase receptor tropomyosin-receptor kinase (Trk), mediate neurotrophin (NT) functions. Beside their classic role in skin innervation, NT and their receptors constitute a complex cutaneous network associated with a number of autocrine and paracrine activities. In this context, the role of p75<sup>NTR</sup> is becoming more and more important. This review will focus on the intriguing functions of p75<sup>NTR</sup> in healthy and diseased skin. First, p75<sup>NTR</sup> counterbalances the proliferative and survival activities of its cognate receptor Trk by inducing keratinocyte apoptosis. In addition, p75<sup>NTR</sup> identifies an early transit-amplifying (TA) keratinocyte population and plays a critical role in keratinocyte stem cell transition to its progeny as well as in epidermal differentiation. p75<sup>NTR</sup> is absent in psoriatic TA cells, thus rendering these cells resistant to apoptosis. On the other hand, p75<sup>NTR</sup> infection restores NT-induced apoptosis in psoriatic keratinocytes. Taken together, these results provide evidence for a critical role of p75<sup>NTR</sup> in epidermal homeostasis, while its lack may account for the TA defect in psoriasis. While the issue of p75<sup>NTR</sup> as a marker of melanoma initiating cells is still to be solved, there is strong evidence that downregulation of this receptor is a precondition to melanoma invasion and metastasis <italic>in vitro</italic> and <italic>in vivo</italic>. All in all, this review points to p75<sup>NTR</sup> as a major actor in both physiologic and pathologic conditions at the skin level.</p>
</abstract>
<kwd-group>
<kwd>p75 neurotrophin receptor</kwd>
<kwd>CD271</kwd>
<kwd>neurotrophins</kwd>
<kwd>skin</kwd>
<kwd>epidermis</kwd>
<kwd>homeostasis</kwd>
<kwd>melanoma</kwd>
<kwd>psoriasis</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="94"/>
<page-count count="8"/>
<word-count count="6163"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>The neurotrophin (NT) family of growth factors that includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), NT-3, and NT-4, plays a fundamental role in the development and maintenance of the nervous system (<xref ref-type="bibr" rid="B1">1</xref>). Each NT exerts its activities through two receptor classes: the high-affinity tropomyosin-receptor kinase (Trk) and the common p75 NT receptor (p75<sup>NTR</sup>, also known as CD271) (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>p75<sup>NTR</sup> belongs to the tumor necrosis factor receptor family and interacts with a variety of ligands and co-receptors to mediate a range of functions, although this interplay is complex and still poorly understood (<xref ref-type="bibr" rid="B3">3</xref>). After ligand activation, p75<sup>NTR</sup> is proteolytically cleaved by &#x003B3;-secretase to give intracellular domain (ICD) that is responsible for specific signaling (<xref ref-type="bibr" rid="B4">4</xref>). Heterodimerization of p75<sup>NTR</sup> with Trk increases the NT/Trk interaction affinity, thus augmenting growth and survival functions. In addition, pro-NTs bind to the sortilin-p75<sup>NTR</sup> complex and initiate cell death signaling (<xref ref-type="bibr" rid="B5">5</xref>). ICD in itself can operate independently of the other co-receptors and the functional activity of p75<sup>NTR</sup> depends on its subcellular localization, on the final location of the fragment (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>), and on which partners it is associated (<xref ref-type="bibr" rid="B8">8</xref>). p75<sup>NTR</sup> interacts with a variety of proteins (<xref ref-type="bibr" rid="B9">9</xref>) that in turn determine signaling through different pathways (<xref ref-type="bibr" rid="B10">10</xref>&#x02013;<xref ref-type="bibr" rid="B12">12</xref>). This interplay allows p75<sup>NTR</sup> to play a flexible, but pivotal role in the regulation of multiple activities and ultimately the fate of the cell. The present review will focus on the current knowledge on p75<sup>NTR</sup> in healthy and diseased skin.</p>
</sec>
<sec id="S2">
<title>p75<sup>NTR</sup> Mediates NT-Sustained Skin Innervation</title>
<p>In the peripheral nervous system, the survival of sensory and sympathetic neurons largely depends on the production by innervated target of NGF and its cognate NTs (<xref ref-type="bibr" rid="B13">13</xref>). Overexpression of NGF in skin determines increase of sensory innervation (<xref ref-type="bibr" rid="B14">14</xref>). NGF production is proportional to the innervation density, and it is retrogradely transported to the cell body of the neuron where it regulates its maintenance (<xref ref-type="bibr" rid="B15">15</xref>). Also in skin, Trk receptors mediate NTs-enhanced cell survival, while p75<sup>NTR</sup> promotes cell death of sensory and sympathetic neurons (<xref ref-type="bibr" rid="B16">16</xref>). Mice carrying a mutation of gene encoding p75<sup>NTR</sup> display a marked decrease in sensory cutaneous innervation, associated with the development of ulcers in the distal extremities (<xref ref-type="bibr" rid="B17">17</xref>), indicating a critical role of p75<sup>NTR</sup> in the survival and functions of sensory neurons. In human skin, the intensity of p75<sup>NTR</sup> immunoreactivity in sensory nerves is stronger in areas where NGF is upregulated in target cells (<xref ref-type="bibr" rid="B18">18</xref>). Moreover, p75<sup>NTR</sup> is strongly increased in sensory fibers in conditions where keratinocytes express high levels of NGF (<xref ref-type="bibr" rid="B19">19</xref>).</p>
</sec>
<sec id="S3">
<title>p75<sup>NTR</sup> Outside the Nervous System</title>
<p>Beside the classical role of maintaining neuronal cells, NT and their receptors possess a range of functions outside the nervous system. Most non-neuronal cells express NT receptors and respond to NT stimuli, which implies for these neural substances, the role of actual growth factors and/or mediators in a number of physiologic (<xref ref-type="bibr" rid="B20">20</xref>) and pathologic conditions (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). On the other hand, the function of p75<sup>NTR</sup> signaling alone or in combination with its co-receptors outside the nervous system has been largely overlooked and remains to be clarified.</p>
</sec>
<sec id="S4">
<title>NT Network in the Skin</title>
<p>Over the past 20&#x02009;years, it has become clear that virtually every cutaneous cell synthesizes and releases NTs and expresses their receptors. Indeed, NGF is produced in basal keratinocytes and is involved in important autocrine functions (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Also, the other NTs are detected in keratinocytes where they exert similar activities (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>In addition, the important observation that human melanocytes express all NTs and their receptors (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>) has been confirmed by the critical role these molecules and their receptors play in melanogenesis (<xref ref-type="bibr" rid="B28">28</xref>) and melanin production (<xref ref-type="bibr" rid="B27">27</xref>). This is further supported by the demonstration that NGF rescue melanocytes from apoptosis (<xref ref-type="bibr" rid="B29">29</xref>) and stimulates their migration and dendricity (<xref ref-type="bibr" rid="B30">30</xref>). Recently, Byun and co-workers have shown that NGF increases melanogenesis and plays a role in the pathogenesis of melasma (<xref ref-type="bibr" rid="B31">31</xref>). Interestingly, NTs and in particular p75<sup>NTR</sup> are expressed in neural crest (NC) cells, the melanocyte precursors (<xref ref-type="bibr" rid="B32">32</xref>).</p>
<p>While the role of NGF in wound repair has been known for a long time (<xref ref-type="bibr" rid="B33">33</xref>), NTs stimulate fibroblasts (<xref ref-type="bibr" rid="B34">34</xref>), one of the most important cell involved in this process. Myofibroblasts produce all NT and their receptors. Both p75<sup>NTR</sup> and Trks mediate fibroblast proliferation, differentiation, and migration. In addition, NGF or BDNF increase the tensile strength in a collagen gel (<xref ref-type="bibr" rid="B35">35</xref>), while tensile stimuli increase NGF in human fibroblasts (<xref ref-type="bibr" rid="B36">36</xref>). Recently, p75<sup>NTR</sup> has been shown to co-immunoprecipitate with the pro-inflammatory phosphodiesterases-4 in myofibroblasts (<xref ref-type="bibr" rid="B37">37</xref>), although the activities of this complex remain to be clarified.</p>
<p>Aloe and Levi-Montalcini originally observed that NGF enhances the number of mast cells in tissues (<xref ref-type="bibr" rid="B38">38</xref>). Since then, it is well accepted that there is a close contact between nerves and mast cells to form the &#x0201C;mast cell-nerve unit&#x0201D; that seems to play a key role in physiologic and pathophysiologic processes (<xref ref-type="bibr" rid="B39">39</xref>), with particular regard to itch and atopic dermatitis (<xref ref-type="bibr" rid="B40">40</xref>). Indeed, high levels of NT-3 are expressed in atopic dermatitis mast cells (<xref ref-type="bibr" rid="B41">41</xref>), and p75<sup>NTR</sup> is induced in lesional atopic mast cells (<xref ref-type="bibr" rid="B42">42</xref>).</p>
<p>These findings strongly indicate the presence of a complex NT network in the skin responsible for a number of autocrine and paracrine functions. In this context, a role for p75<sup>NTR</sup> has recently begun to emerge.</p>
</sec>
<sec id="S5">
<title>p75 and Hair Follicle</title>
<p>Neurotrophins and their receptors are involved in hair follicle morphogenesis in a complex manner. Consistent with the opposite roles of the two NT receptors, it would appear that NGF/TrkA promotes an anagen supporting role, whereas proNGF/p75 interaction is associated with a catagen-promoting effect (<xref ref-type="bibr" rid="B43">43</xref>). Moreover, NGF, but not BDNF, accelerates hair follicle development (<xref ref-type="bibr" rid="B44">44</xref>). On the other hand, BDNF inhibits hair shaft elongation and provokes catagen (<xref ref-type="bibr" rid="B45">45</xref>). NGF expression is also observed in keratinocytes of human hair follicles (<xref ref-type="bibr" rid="B46">46</xref>), with important implications for morphogenesis (<xref ref-type="bibr" rid="B47">47</xref>). Adly and co-workers reported that p75<sup>NTR</sup> protein displays a hair cycle-dependent fluctuation in human scalp (<xref ref-type="bibr" rid="B48">48</xref>), and p75<sup>NTR</sup> induces hair follicle involution <italic>via</italic> apoptosis (<xref ref-type="bibr" rid="B49">49</xref>).</p>
</sec>
<sec id="S6">
<title>p75<sup>NTR</sup> and Epidermal Homeostasis</title>
<p>Epidermal homeostasis is based on a fine balance between keratinocyte proliferation, differentiation, and apoptosis (<xref ref-type="bibr" rid="B50">50</xref>). Constant epidermal regeneration is achieved by stem cells that are slow-cycling and possess the capacity of self-renew (<xref ref-type="bibr" rid="B51">51</xref>). Keratinocyte stem cells (KSC) reside in the basal layer and generate transit-amplifying (TA) cells that undergo a limited number of cell divisions before committing to terminal differentiation (<xref ref-type="bibr" rid="B52">52</xref>), although this model has been recently questioned (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>Psoriasis is an immune-mediated dermatosis where alterations of epidermal homeostasis account for the main pathologic and clinical outcome. Indeed, psoriasis is characterized by keratinocyte hyperproliferation, abnormal differentiation, and increased resistance to apoptosis (<xref ref-type="bibr" rid="B55">55</xref>), resulting in excessive epidermal thickness, the key feature of psoriatic plaque. Thus, psoriasis is a perfect model of altered epidermal homeostasis that can be exploited for evaluating the expression and function of several molecules, including NTs.</p>
<p>Normal human keratinocytes synthesize and secrete all NTs and express their receptors. NGF is predominantly expressed in KSC (<xref ref-type="bibr" rid="B25">25</xref>), while TrkA is located only in basal keratinocytes with a uniform pattern (<xref ref-type="bibr" rid="B56">56</xref>). On the other hand, p75<sup>NTR</sup> is expressed in a subpopulation of basal keratinocytes with an irregular distribution (<xref ref-type="bibr" rid="B57">57</xref>). NGF levels are increased in psoriatic tissue (<xref ref-type="bibr" rid="B58">58</xref>) and keratinocytes (<xref ref-type="bibr" rid="B59">59</xref>). TrkA receptor is overexpressed throughout the epidermal layers in psoriatic skin (<xref ref-type="bibr" rid="B56">56</xref>), whereas p75<sup>NTR</sup> expression completely disappears in lesional psoriatic epidermis (<xref ref-type="bibr" rid="B57">57</xref>). These findings might be consistent with the general concept on the opposing effects Trks and p75<sup>NTR</sup> mediate in the nervous system (<xref ref-type="bibr" rid="B60">60</xref>). The following data confirm that this is actually the case also at the skin level.</p>
<p>Indeed, NGF or NT-3 stimulates keratinocyte growth (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B61">61</xref>), and transfecting HaCat cells with TrkA enhance cell proliferation (<xref ref-type="bibr" rid="B62">62</xref>), indicating that NTs act as mitogens through their high-affinity receptor. Consistently, K252, a natural alkaloid that blocks Trk phosphorylation, thus inhibiting NT functions, prevents NGF-induced keratinocyte proliferation (<xref ref-type="bibr" rid="B23">23</xref>). In line with the increased expression of Trk and NGF (<xref ref-type="bibr" rid="B63">63</xref>) in psoriasis, topical treatment with K252 improves psoriasis in the immunodeficient mouse&#x02013;human skin model (<xref ref-type="bibr" rid="B64">64</xref>). In psoriasis, keratinocyte apoptosis is spontaneously decreased (<xref ref-type="bibr" rid="B65">65</xref>), and psoriatic keratinocytes are resistant to apoptosis (<xref ref-type="bibr" rid="B66">66</xref>). Recently, PageRank analysis revealed a group of hub genes with anti-apoptotic functions in psoriasis (<xref ref-type="bibr" rid="B67">67</xref>).</p>
<p>Endogenous NGF acts as a survival factor for human keratinocytes through Trk receptor, as K252 induces cell death in these cells, by maintaining constant levels of the anti-apoptotic protein Bcl-2 (<xref ref-type="bibr" rid="B24">24</xref>). Furthermore, NGF protects keratinocytes from ultraviolet-B-induced apoptosis by preventing the cleavage of the enzyme poly (ADP-ribose) polymerase (<xref ref-type="bibr" rid="B61">61</xref>). Taken together, these data support the notion that NTs and Trk receptors mediate proliferative and survival activities in human keratinocytes. Abnormal mitotic and apoptotic processes mediated by NTs lead to the imbalanced epidermal homeostasis resulting in the excessive epidermal thickening observed in psoriasis (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>p75<sup>NTR</sup> in epidermal homeostasis and psoriasis</bold>. In normal epidermis, there is a balance between p75<sup>NTR</sup> and tropomyosin-receptor kinase (Trk) receptors that controls proliferation, differentiation, and apoptosis and allows a perfect homeostasis. Upregulation of Trk and lack of p75<sup>NTR</sup> cause hyperproliferation, abnormal differentiation and reduced apoptosis that in turn are responsible for the altered epidermal homeostasis typical of psoriasis.</p></caption>
<graphic xlink:href="fmed-04-00022-g001.tif"/>
</fig>
<p>The absence of p75<sup>NTR</sup> as opposed to the increased Trk expression in lesional psoriatic epidermis (<xref ref-type="bibr" rid="B57">57</xref>) supports the hypothesis that an imbalance of the NT receptors could play an important role in the alterations of epidermal homeostasis observed in psoriasis. In normal human skin, binding of p75<sup>NTR</sup> with proper ligands mediates keratinocyte apoptosis. In fact, &#x003B2; amyloid, able to bind directly to p75<sup>NTR</sup> (<xref ref-type="bibr" rid="B68">68</xref>), activates caspase-3 only in keratinocytes expressing the low-affinity NT receptor. In addition, BDNF or NT-4, which signals only through p75<sup>NTR</sup>, induces apoptosis in human keratinocytes (<xref ref-type="bibr" rid="B57">57</xref>). In the nervous system, when both NT receptors are expressed, NT binds to Trk/p75 complex and mediate survival (<xref ref-type="bibr" rid="B69">69</xref>). On the other hand, in normal human keratinocytes, where both receptors are expressed, it appears that p75<sup>NTR</sup> can signal independently of Trk. This is in line with other studies in non-neuronal epithelial tissues. In fact, BDNF was recently shown to induce apoptosis in gingival epithelium <italic>via</italic> p75<sup>NTR</sup> (<xref ref-type="bibr" rid="B70">70</xref>), and p75<sup>NTR</sup> mediates apoptosis in prostate cancer cells (<xref ref-type="bibr" rid="B71">71</xref>), in the presence of Trk receptors. p75<sup>NTR</sup> independent signal mediating apoptosis in keratinocytes is further confirmed by the co-immunoprecipitation with its interacting protein NRAGE (<xref ref-type="bibr" rid="B57">57</xref>) that is known to disrupt p75<sup>NTR</sup>-Trk complex and to cause cell death through JNK-dependent pathway (<xref ref-type="bibr" rid="B72">72</xref>). In keeping with this concept, BDNF induces apoptosis in human keratinocytes through the phosphorylation of JNK (<xref ref-type="bibr" rid="B57">57</xref>). Taken together, these results indicate that p75<sup>NTR</sup> counteracts the survival and proliferative activities of Trk receptors, thus contributing to a normal epidermal homeostasis (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<p>In human epidermis, differentiation begins when the transition from KSC to TA cells occurs, although the mechanisms underlying this process are still partially unknown.</p>
<p>p75<sup>NTR</sup> is predominantly expressed in the keratinocyte subpopulation enriched in TA cells (<xref ref-type="bibr" rid="B57">57</xref>). p75<sup>NTR</sup>-positive keratinocytes sorted from freshly isolated TA cells still retain KSC markers, such as survivin and keratin 15, while they express less markers of differentiation, as compared to p75<sup>NTR</sup>-negative cells. In addition, p75<sup>NTR</sup>-positive TA cells display a higher proliferative capacity and a better colony forming efficiency, as compared to p75<sup>NTR</sup>-negative cells. Finally, human reconstructed epidermis derived from p75<sup>NTR</sup>-positive TA cells express markers of early differentiation (<xref ref-type="bibr" rid="B73">73</xref>). This indicates that p75<sup>NTR</sup> identifies a population of early TA cells. A population of early TA has been already detected in the hair follicle (<xref ref-type="bibr" rid="B74">74</xref>) and in the interfollicular epidermis (<xref ref-type="bibr" rid="B75">75</xref>) and appears to be critical in the first steps of the differentiation process (<xref ref-type="bibr" rid="B76">76</xref>). p75<sup>NTR</sup> protein that exerts its activities at the boundary between KSC and TA could function as early trigger of keratinocyte differentiation. In fact, silencing p75<sup>NTR</sup> prevents calcium-induced keratinocyte differentiation and converts TA cells into a KSC phenotype. Moreover, overexpression of p75<sup>NTR</sup> in KSC results in a keratinocyte subpopulation with the features of TA cells (<xref ref-type="bibr" rid="B73">73</xref>). These results indicate that p75<sup>NTR</sup> could act as a &#x0201C;switch on-off&#x0201D; protein that critically regulates KSC-progeny transition and differentiation in human epidermis (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<p>Excessive expansion of the TA cells compartment has been recently described in psoriatic skin (<xref ref-type="bibr" rid="B77">77</xref>), where a defect in TA subpopulation seems to account for the epidermal abnormalities observed in the disease (<xref ref-type="bibr" rid="B78">78</xref>). In addition, <italic>in silico</italic> studies have simulated psoriasis by altering the TA cells (<xref ref-type="bibr" rid="B79">79</xref>), and psoriatic TA cells are more advanced in their life cycle than their normal counterpart (<xref ref-type="bibr" rid="B80">80</xref>). p75<sup>NTR</sup> levels are strikingly reduced in psoriatic TA (<xref ref-type="bibr" rid="B57">57</xref>), and the lack of p75<sup>NTR</sup> seems to account for the reduced apoptosis of psoriatic keratinocytes. Indeed, BDNF fail to induce cell death in these cells, while overexpression of p75<sup>NTR</sup> restores their susceptibility to apoptosis (<xref ref-type="bibr" rid="B73">73</xref>). These findings suggest that alterations of the TA cell in psoriasis are at least in part due to a defect in p75<sup>NTR</sup>. Interestingly, skin equivalent models derived from p75<sup>NTR</sup>-negative TA cells display a psoriasiform phenotype&#x02009;(<xref ref-type="bibr" rid="B73">73</xref>) in line with the absence of the receptor protein in psoriasis (<xref ref-type="bibr" rid="B57">57</xref>). Because p75<sup>NTR</sup> plays a critical role in the early keratinocyte differentiation, it is tempting to speculate that the intrinsic defects in psoriatic epidermis occur in the early TA cells where the absence of p75<sup>NTR</sup> may account for the altered epidermal homeostasis of the disease. It has been shown that when keratinocytes exit the niche, they could undergo either differentiation or programmed cell death (<xref ref-type="bibr" rid="B81">81</xref>). Although p75<sup>NTR</sup> is clearly involved in both processes in human epidermis, the different triggers and pathways associated with the functions of the receptor remain to be elucidated.</p>
</sec>
<sec id="S7">
<title>p75<sup>NTR</sup> and Melanoma: More than Just a Marker</title>
<p>Melanoma cell lines synthesize and secrete all NTs and express NT receptors (<xref ref-type="bibr" rid="B82">82</xref>). p75<sup>NTR</sup> was first isolated from a melanoma cell line, and it has become a useful tool for immunohistochemical diagnosis of melanoma (<xref ref-type="bibr" rid="B83">83</xref>). High degree of p75<sup>NTR</sup> expression allows a better diagnosis of desmoplastic melanoma (<xref ref-type="bibr" rid="B84">84</xref>) and the distinction between spindle melanoma and other spindle cell tumors (<xref ref-type="bibr" rid="B85">85</xref>).</p>
<p>According to the &#x0201C;cancer stem cell&#x0201D; theory, a distinct subpopulation of melanoma cells (melanoma initiating cells, MIC) would account for the high tumorigenic properties, tumor heterogeneity, invasiveness, and drug resistance (<xref ref-type="bibr" rid="B86">86</xref>). p75<sup>NTR</sup> has received a special attention as a possible MIC marker because it is a marker of NC cells, the melanocyte precursors (<xref ref-type="bibr" rid="B87">87</xref>), and for the similarities between NC stem cells and melanoma cells (<xref ref-type="bibr" rid="B88">88</xref>). Yet, whether p75<sup>NTR</sup> identifies a group of highly tumorigenic MIC has not been clarified. It was first demonstrated that MIC express high levels of p75<sup>NTR</sup> and p75<sup>NTR</sup>-positive, but not p75<sup>NTR</sup>-negative transplanted melanoma cells are capable of inducing metastasis <italic>in vivo</italic> (<xref ref-type="bibr" rid="B89">89</xref>). On the other hand, Quintana and co-workers could not confirm these data, by showing that p75<sup>NTR</sup> -positive or p75<sup>NTR</sup> -negative melanoma cells have the same tumorigenic potential (<xref ref-type="bibr" rid="B90">90</xref>). Recently, Boyle and colleagues, using different patient-derived xenograft assays, have clearly shown that p75<sup>NTR</sup>-negative and p75<sup>NTR</sup>-positive melanoma cells from each of the patients had similar tumorigenic activity, concluding that p75<sup>NTR</sup> expression is unstable and not associated with increased tumorigenicity (<xref ref-type="bibr" rid="B91">91</xref>). This work also questions its role as a marker of melanoma aggressiveness (<xref ref-type="bibr" rid="B91">91</xref>). Consistently, p75<sup>NTR</sup> expression inversely correlates with hypoxia and melanoma invasiveness <italic>in vivo</italic> (<xref ref-type="bibr" rid="B92">92</xref>).</p>
<p>To definitely assess the role of p75<sup>NTR</sup> in melanoma, we have recently carried out an extensive study <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B93">93</xref>). In skin equivalent models, p75<sup>NTR</sup> is highly expressed in early melanomas at the epidermal level and tends to disappear when melanoma starts to invade the dermis. In addition, p75<sup>NTR</sup> is completely absent in skin reconstructs derived from metastatic cell lines. p75<sup>NTR</sup> expression is highest in spheroids derived from primary melanoma cells, it decreases in cells derived from metastatic melanomas to disappear in highly invasive spheroids. p75<sup>NTR</sup>-negative cells show greater proliferation and invasiveness <italic>in vitro</italic> and are associated with a higher number of metastases in zebrafish, as compared with p75<sup>NTR</sup>-positive cells. Moreover, silencing p75<sup>NTR</sup> induces a more aggressive phenotype in spheroids and in the animal model. By contrast, p75<sup>NTR</sup> overexpression reduces invasiveness <italic>in vitro</italic> and strikingly reduces the number of metastases in zebrafish. This seems to indicate that p75<sup>NTR</sup> switch off is critical for melanoma progression and metastasis (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>p75 neurotrophin receptor (p75<sup>NTR</sup>) and melanoma</bold>. p75<sup>NTR</sup> is associated with less aggressive melanoma, while it tends to decrease and disappear during melanoma invasion and metastasis.</p></caption>
<graphic xlink:href="fmed-04-00022-g002.tif"/>
</fig>
</sec>
<sec id="S8">
<title>Conclusion</title>
<p>There is compelling evidence that, in the context of the skin NT network, p75<sup>NTR</sup> is a major actor in both physiological and pathological conditions. In healthy skin, p75<sup>NTR</sup>-triggered differentiation and de-differentiation during KSC to progeny transition awaits confirmation in other epidermal stem cell compartments as well as in the mouse model. In addition, more studies are needed to understand the mechanisms underlying the absence of p75<sup>NTR</sup> protein in psoriasis, and whether the lack of the receptor, that is critical for epidermal homeostasis, is associated with a psoriatic phenotype also <italic>in vivo</italic>.</p>
<p>While the downregulation of p75<sup>NTR</sup> as a precondition for melanoma progression and metastasis is unquestionable, the molecular mechanisms associated with this function are not fully clarified. The low levels of &#x003B2;<sub>1</sub> integrin and the decreased of cell-to-cell adhesion in the absence of p75<sup>NTR</sup> could predispose melanoma to increased invasiveness (<xref ref-type="bibr" rid="B93">93</xref>). Furthermore, melanoma is characterized by an alteration of the apoptotic machinery. The lack of p75<sup>NTR</sup> that exerts pro-apoptotic functions in melanoma (<xref ref-type="bibr" rid="B94">94</xref>), could favor tumor cell survival and metastasis.</p>
</sec>
<sec id="S9" sec-type="author-contributor">
<title>Author Contributions</title>
<p>The author confirms being the sole contributor of this work and approved it for publication.</p>
</sec>
<sec id="S10">
<title>Conflict of Interest Statement</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>The author would like to thank Roberta Lotti and Annalisa Saltari for critical revising and editing of the manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bothwell</surname> <given-names>M</given-names></name></person-group>. <article-title>NGF, BDNF, NT3, and NT4</article-title>. <source>Handb Exp Pharmacol</source> (<year>2014</year>) <volume>220</volume>:<fpage>3</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1007/978-3-642-45106-5_1</pub-id><pub-id pub-id-type="pmid">24668467</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marchetti</surname> <given-names>L</given-names></name> <name><surname>Luin</surname> <given-names>S</given-names></name> <name><surname>Bonsignore</surname> <given-names>F</given-names></name> <name><surname>de Nadai</surname> <given-names>T</given-names></name> <name><surname>Beltram</surname> <given-names>F</given-names></name> <name><surname>Cattaneo</surname> <given-names>A</given-names></name></person-group>. <article-title>Ligand-induced dynamics of neurotrophin receptors investigated by single-molecule imaging approaches</article-title>. <source>Int J Mol Sci</source> (<year>2015</year>) <volume>16</volume>(<issue>1</issue>):<fpage>1949</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.3390/ijms16011949</pub-id><pub-id pub-id-type="pmid">25603178</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ib&#x000E1;&#x000F1;ez</surname> <given-names>CF</given-names></name> <name><surname>Simi</surname> <given-names>A</given-names></name></person-group>. <article-title>p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity</article-title>. <source>Trends Neurosci</source> (<year>2012</year>) <volume>35</volume>(<issue>7</issue>):<fpage>431</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.tins.2012.03.007</pub-id><pub-id pub-id-type="pmid">22503537</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vilar</surname> <given-names>M</given-names></name> <name><surname>Mira</surname> <given-names>H</given-names></name></person-group>. <article-title>Regulation of neurogenesis by neurotrophins during adulthood: expected and unexpected roles</article-title>. <source>Front Neurosci</source> (<year>2016</year>) <volume>10</volume>:<fpage>26</fpage>.<pub-id pub-id-type="doi">10.3389/fnins.2016.00026</pub-id><pub-id pub-id-type="pmid">26903794</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meeker</surname> <given-names>R</given-names></name> <name><surname>Williams</surname> <given-names>K</given-names></name></person-group>. <article-title>Dynamic nature of the p75 neurotrophin receptor in response to injury and disease</article-title>. <source>J Neuroimmune Pharmacol</source> (<year>2014</year>) <volume>9</volume>(<issue>5</issue>):<fpage>615</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1007/s11481-014-9566-9</pub-id><pub-id pub-id-type="pmid">25239528</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bronfman</surname> <given-names>FC</given-names></name> <name><surname>Fainzilber</surname> <given-names>M</given-names></name></person-group>. <article-title>Multi-tasking by the p75 neurotrophin receptor: sortilin things out?</article-title> <source>EMBO Rep</source> (<year>2004</year>) <volume>5</volume>(<issue>9</issue>):<fpage>867</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1038/sj.embor.7400219</pub-id><pub-id pub-id-type="pmid">15470383</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skeldal</surname> <given-names>S</given-names></name> <name><surname>Matusica</surname> <given-names>D</given-names></name> <name><surname>Nykjaer</surname> <given-names>A</given-names></name> <name><surname>Coulson</surname> <given-names>EJ</given-names></name></person-group>. <article-title>Proteolytic processing of the p75 neurotrophin receptor: a prerequisite for signalling? Neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR)</article-title>. <source>Bioessays</source> (<year>2011</year>) <volume>33</volume>(<issue>8</issue>):<fpage>614</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1002/bies.201100036</pub-id><pub-id pub-id-type="pmid">21717487</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vilar</surname> <given-names>M</given-names></name> <name><surname>Charalampopoulos</surname> <given-names>I</given-names></name> <name><surname>Kenchappa</surname> <given-names>RS</given-names></name> <name><surname>Reversi</surname> <given-names>A</given-names></name> <name><surname>Klos-Applequist</surname> <given-names>JM</given-names></name> <name><surname>Karaca</surname> <given-names>E</given-names></name> <etal/></person-group> <article-title>Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor</article-title>. <source>J Cell Sci</source> (<year>2009</year>) <volume>122</volume>:<fpage>3351</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1242/jcs.055061</pub-id><pub-id pub-id-type="pmid">19706676</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname> <given-names>PA</given-names></name></person-group>. <article-title>p75NTR is positively promiscuous: novel partners and new insights</article-title>. <source>Neuron</source> (<year>2004</year>) <volume>42</volume>:<fpage>529</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuron.2004.04.001</pub-id><pub-id pub-id-type="pmid">15157416</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Troy</surname> <given-names>CM</given-names></name> <name><surname>Friedman</surname> <given-names>JE</given-names></name> <name><surname>Friedman</surname> <given-names>WJ</given-names></name></person-group>. <article-title>Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases</article-title>. <source>J Biol Chem</source> (<year>2002</year>) <volume>277</volume>:<fpage>34295</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M205167200</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname> <given-names>EB</given-names></name> <name><surname>Howell</surname> <given-names>J</given-names></name> <name><surname>Kodama</surname> <given-names>Y</given-names></name> <name><surname>Barker</surname> <given-names>PA</given-names></name> <name><surname>Bonni</surname> <given-names>A</given-names></name></person-group>. <article-title>Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis</article-title>. <source>J Neurosci</source> (<year>2004</year>) <volume>24</volume>(<issue>40</issue>):<fpage>8762</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2953-04.2004</pub-id><pub-id pub-id-type="pmid">15470142</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linggi</surname> <given-names>MS</given-names></name> <name><surname>Burke</surname> <given-names>TL</given-names></name> <name><surname>Williams</surname> <given-names>BB</given-names></name> <name><surname>Harrington</surname> <given-names>A</given-names></name> <name><surname>Kraemer</surname> <given-names>R</given-names></name> <name><surname>Hempstead</surname> <given-names>BL</given-names></name> <etal/></person-group> <article-title>Neurotrophin receptor interacting factor (NRIF) is an essential mediator of apoptotic signaling by the p76 neurotrophic receptor</article-title>. <source>J Biol Chem</source> (<year>2005</year>) <volume>280</volume>(<issue>14</issue>):<fpage>13801</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M410435200</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delcroix</surname> <given-names>JD</given-names></name> <name><surname>Valletta</surname> <given-names>JS</given-names></name> <name><surname>Wu</surname> <given-names>C</given-names></name> <name><surname>Hunt</surname> <given-names>SJ</given-names></name> <name><surname>Kowal</surname> <given-names>AS</given-names></name> <name><surname>Mobley</surname> <given-names>WC</given-names></name></person-group>. <article-title>NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals</article-title>. <source>Neuron</source> (<year>2003</year>) <volume>39</volume>:<fpage>69</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/S0896-6273(03)00397-0</pub-id><pub-id pub-id-type="pmid">12848933</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>BM</given-names></name> <name><surname>Fundin</surname> <given-names>BT</given-names></name> <name><surname>Albers</surname> <given-names>KM</given-names></name> <name><surname>Goodness</surname> <given-names>TP</given-names></name> <name><surname>Cronk</surname> <given-names>KM</given-names></name> <name><surname>Rice</surname> <given-names>FL</given-names></name></person-group>. <article-title>Overexpression of nerve growth factor in skin causes preferential increases among innervation to specific sensory targets</article-title>. <source>J Comp Neurol</source> (<year>1997</year>) <volume>387</volume>(<issue>4</issue>):<fpage>489</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19971103)387:4&#x0003C;489::AID-CNE2&#x0003E;3.0.CO;2-Z</pub-id><pub-id pub-id-type="pmid">9373009</pub-id></citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname> <given-names>SL</given-names></name> <name><surname>Spori</surname> <given-names>B</given-names></name> <name><surname>Vizard</surname> <given-names>TN</given-names></name> <name><surname>Davies</surname> <given-names>AM</given-names></name></person-group>. <article-title>Selective regulation of nerve growth factor expression in developing cutaneous tissue by early sensory innervation</article-title>. <source>Neural Dev</source> (<year>2011</year>) <volume>6</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1186/1749-8104-6-18</pub-id><pub-id pub-id-type="pmid">21529369</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bothwell</surname> <given-names>M</given-names></name></person-group>. <article-title>Neurotrophin function in skin</article-title>. <source>J Investig Dermatol Symp Proc</source> (<year>1997</year>) <volume>2</volume>(<issue>1</issue>):<fpage>27</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1038/jidsymp.1997.7</pub-id><pub-id pub-id-type="pmid">9487012</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>KF</given-names></name> <name><surname>Li</surname> <given-names>E</given-names></name> <name><surname>Huber</surname> <given-names>LJ</given-names></name> <name><surname>Landis</surname> <given-names>SC</given-names></name> <name><surname>Sharpe</surname> <given-names>AH</given-names></name> <name><surname>Chao</surname> <given-names>MV</given-names></name> <etal/></person-group> <article-title>Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system</article-title>. <source>Cell</source> (<year>1992</year>) <volume>69</volume>(<issue>5</issue>):<fpage>737</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1016/0092-8674(92)90286-L</pub-id><pub-id pub-id-type="pmid">1317267</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname> <given-names>YC</given-names></name> <name><surname>Hagstr&#x000F6;mer</surname> <given-names>L</given-names></name> <name><surname>Emtestam</surname> <given-names>L</given-names></name> <name><surname>Johansson</surname> <given-names>O</given-names></name></person-group>. <article-title>Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study</article-title>. <source>Arch Dermatol Res</source> (<year>2006</year>) <volume>298</volume>(<issue>1</issue>):<fpage>31</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1007/s00403-006-0657-1</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raychaudhuri</surname> <given-names>SP</given-names></name> <name><surname>Raychaudhuri</surname> <given-names>SK</given-names></name></person-group>. <article-title>Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis</article-title>. <source>Prog Brain Res</source> (<year>2004</year>) <volume>146</volume>:<fpage>433</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/S0079-6123(03)46027-5</pub-id><pub-id pub-id-type="pmid">14699978</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aloe</surname> <given-names>L</given-names></name> <name><surname>Rocco</surname> <given-names>ML</given-names></name> <name><surname>Bianchi</surname> <given-names>P</given-names></name> <name><surname>Manni</surname> <given-names>L</given-names></name></person-group>. <article-title>Nerve growth factor: from the early discoveries to the potential clinical use</article-title>. <source>J Transl Med</source> (<year>2012</year>) <volume>10</volume>(<issue>239</issue>):<fpage>1</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1186/1479-5876-10-239</pub-id><pub-id pub-id-type="pmid">23190582</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scuri</surname> <given-names>M</given-names></name> <name><surname>Samsell</surname> <given-names>L</given-names></name> <name><surname>Piedimonte</surname> <given-names>G</given-names></name></person-group>. <article-title>The role of neurotrophins in inflammation and allergy</article-title>. <source>Inflamm Allergy Drug Targets</source> (<year>2010</year>) <volume>9</volume>(<issue>3</issue>):<fpage>173</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.2174/187152810792231913</pub-id><pub-id pub-id-type="pmid">20553229</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seidel</surname> <given-names>MF</given-names></name> <name><surname>Lane</surname> <given-names>NE</given-names></name></person-group>. <article-title>Control of arthritis pain with anti-nerve-growth factor: risk and benefit</article-title>. <source>Curr Rheumatol Rep</source> (<year>2012</year>) <volume>14</volume>(<issue>6</issue>):<fpage>583</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1007/s11926-012-0289-8</pub-id><pub-id pub-id-type="pmid">22948388</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pincelli</surname> <given-names>C</given-names></name> <name><surname>Sevignani</surname> <given-names>C</given-names></name> <name><surname>Manfredini</surname> <given-names>R</given-names></name> <name><surname>Grande</surname> <given-names>A</given-names></name> <name><surname>Fantini</surname> <given-names>F</given-names></name> <name><surname>Bracci-Laudiero</surname> <given-names>L</given-names></name> <etal/></person-group> <article-title>Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes</article-title>. <source>J Invest Dermatol</source> (<year>1994</year>) <volume>103</volume>(<issue>1</issue>):<fpage>13</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/1523-1747.ep12388914</pub-id><pub-id pub-id-type="pmid">8027574</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pincelli</surname> <given-names>C</given-names></name> <name><surname>Haake</surname> <given-names>AR</given-names></name> <name><surname>Benassi</surname> <given-names>L</given-names></name> <name><surname>Grassilli</surname> <given-names>E</given-names></name> <name><surname>Magnoni</surname> <given-names>C</given-names></name> <name><surname>Ottani</surname> <given-names>D</given-names></name> <etal/></person-group> <article-title>Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (TRK): a role for BCL-2</article-title>. <source>J Invest Dermatol</source> (<year>1997</year>) <volume>109</volume>(<issue>6</issue>):<fpage>757</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1111/1523-1747.ep12340768</pub-id><pub-id pub-id-type="pmid">9406817</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marconi</surname> <given-names>A</given-names></name> <name><surname>Terracina</surname> <given-names>M</given-names></name> <name><surname>Fila</surname> <given-names>C</given-names></name> <name><surname>Franchi</surname> <given-names>J</given-names></name> <name><surname>Bont&#x000E9;</surname> <given-names>F</given-names></name> <name><surname>Romagnoli</surname> <given-names>G</given-names></name> <etal/></person-group> <article-title>Expression and function of neurotrophins and their receptors in cultured human keratinocytes</article-title>. <source>J Invest Dermatol</source> (<year>2003</year>) <volume>121</volume>(<issue>6</issue>):<fpage>1515</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1111/j.1523-1747.2003.12624.x</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaar</surname> <given-names>M</given-names></name> <name><surname>Eller</surname> <given-names>MS</given-names></name> <name><surname>DiBenedetto</surname> <given-names>P</given-names></name> <name><surname>Reenstra</surname> <given-names>WR</given-names></name> <name><surname>Zhai</surname> <given-names>S</given-names></name> <name><surname>McQuaid</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes</article-title>. <source>J Clin Invest</source> (<year>1994</year>) <volume>94</volume>(<issue>4</issue>):<fpage>1550</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1172/JCI117496</pub-id><pub-id pub-id-type="pmid">7929831</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marconi</surname> <given-names>A</given-names></name> <name><surname>Panza</surname> <given-names>MC</given-names></name> <name><surname>Bonnet-Duquennoy</surname> <given-names>M</given-names></name> <name><surname>Lazou</surname> <given-names>K</given-names></name> <name><surname>Kurfurst</surname> <given-names>R</given-names></name> <name><surname>Truzzi</surname> <given-names>F</given-names></name> <etal/></person-group> <article-title>Expression and function of neurotrophins and their receptors in human melanocytes</article-title>. <source>Int J Cosmet Sci</source> (<year>2006</year>) <volume>28</volume>(<issue>4</issue>):<fpage>255</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1111/j.1467-2494.2006.00321.x</pub-id><pub-id pub-id-type="pmid">18489265</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname> <given-names>Y</given-names></name> <name><surname>Hearing</surname> <given-names>VJ</given-names></name></person-group>. <article-title>Physiological factors that regulate skin pigmentation</article-title>. <source>Biofactors</source> (<year>2009</year>) <volume>35</volume>(<issue>2</issue>):<fpage>193</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1002/biof.29</pub-id><pub-id pub-id-type="pmid">19449448</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname> <given-names>S</given-names></name> <name><surname>Yaar</surname> <given-names>M</given-names></name> <name><surname>Doyle</surname> <given-names>SM</given-names></name> <name><surname>Gilchrest</surname> <given-names>BA</given-names></name></person-group>. <article-title>Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels</article-title>. <source>Exp Cell Res</source> (<year>1996</year>) <volume>224</volume>(<issue>2</issue>):<fpage>335</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1006/excr.1996.0143</pub-id><pub-id pub-id-type="pmid">8612710</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaar</surname> <given-names>M</given-names></name> <name><surname>Grossman</surname> <given-names>K</given-names></name> <name><surname>Eller</surname> <given-names>M</given-names></name> <name><surname>Gilchrest</surname> <given-names>BA</given-names></name></person-group>. <article-title>Evidence for nerve growth factor-mediated paracrine effects in human epidermis</article-title>. <source>J Cell Biol</source> (<year>1991</year>) <volume>115</volume>:<fpage>821</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1083/jcb.115.3.821</pub-id><pub-id pub-id-type="pmid">1655813</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Byun</surname> <given-names>JW</given-names></name> <name><surname>Park</surname> <given-names>IS</given-names></name> <name><surname>Choi</surname> <given-names>GS</given-names></name> <name><surname>Shin</surname> <given-names>J</given-names></name></person-group>. <article-title>Role of fibroblast-derived factors in the pathogenesis of melasma</article-title>. <source>Clin Exp Dermatol</source> (<year>2016</year>) <volume>41</volume>(<issue>6</issue>):<fpage>601</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/ced.12874</pub-id><pub-id pub-id-type="pmid">27416970</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pelaez</surname> <given-names>D</given-names></name> <name><surname>Huang</surname> <given-names>CY</given-names></name> <name><surname>Cheung</surname> <given-names>HS</given-names></name></person-group>. <article-title>Isolation of pluripotent neural crest-derived stem cells from adult human tissues by connexin-43 enrichment</article-title>. <source>Stem Cells Dev</source> (<year>2013</year>) <volume>22</volume>(<issue>21</issue>):<fpage>2906</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1089/scd.2013.0090</pub-id><pub-id pub-id-type="pmid">23750535</pub-id></citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname> <given-names>H</given-names></name> <name><surname>Koyama</surname> <given-names>H</given-names></name> <name><surname>Sato</surname> <given-names>H</given-names></name> <name><surname>Sawada</surname> <given-names>J</given-names></name> <name><surname>Itakura</surname> <given-names>A</given-names></name> <name><surname>Tanaka</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice</article-title>. <source>J Exp Med</source> (<year>1998</year>) <volume>187</volume>(<issue>3</issue>):<fpage>297</fpage>&#x02013;<lpage>306</lpage>.<pub-id pub-id-type="doi">10.1084/jem.187.3.297</pub-id><pub-id pub-id-type="pmid">9449710</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Micera</surname> <given-names>A</given-names></name> <name><surname>Vigneti</surname> <given-names>E</given-names></name> <name><surname>Pickholtz</surname> <given-names>D</given-names></name> <name><surname>Reich</surname> <given-names>R</given-names></name> <name><surname>Pappo</surname> <given-names>O</given-names></name> <name><surname>Bonini</surname> <given-names>S</given-names></name> <etal/></person-group> <article-title>Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2001</year>) <volume>98</volume>(<issue>11</issue>):<fpage>6162</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.101130898</pub-id><pub-id pub-id-type="pmid">11344264</pub-id></citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palazzo</surname> <given-names>E</given-names></name> <name><surname>Marconi</surname> <given-names>A</given-names></name> <name><surname>Truzzi</surname> <given-names>F</given-names></name> <name><surname>Dallaglio</surname> <given-names>K</given-names></name> <name><surname>Petrachi</surname> <given-names>T</given-names></name> <name><surname>Humbert</surname> <given-names>P</given-names></name> <etal/></person-group> <article-title>Role of neurotrophins on dermal fibroblast survival and differentiation</article-title>. <source>J Cell Physiol</source> (<year>2012</year>) <volume>227</volume>(<issue>3</issue>):<fpage>1017</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1002/jcp.22811</pub-id><pub-id pub-id-type="pmid">21503896</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>M</given-names></name> <name><surname>Shin</surname> <given-names>DW</given-names></name> <name><surname>Shin</surname> <given-names>H</given-names></name> <name><surname>Noh</surname> <given-names>M</given-names></name> <name><surname>Shin</surname> <given-names>JH</given-names></name></person-group>. <article-title>Tensile stimuli increase nerve growth factor in human dermal fibroblasts independent of tension-induced TGF&#x003B2; production</article-title>. <source>Exp Dermatol</source> (<year>2013</year>) <volume>22</volume>(<issue>1</issue>):<fpage>72</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1111/exd.12064</pub-id></citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname> <given-names>PH</given-names></name> <name><surname>Truzzi</surname> <given-names>F</given-names></name> <name><surname>Parton</surname> <given-names>A</given-names></name> <name><surname>Wu</surname> <given-names>L</given-names></name> <name><surname>Kosek</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>LH</given-names></name> <etal/></person-group> <article-title>Phosphodiesterase 4 in inflammatory diseases: effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex</article-title>. <source>Cell Signal</source> (<year>2016</year>) <volume>28</volume>(<issue>7</issue>):<fpage>753</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1016/j.cellsig.2016.01.007</pub-id><pub-id pub-id-type="pmid">26806620</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aloe</surname> <given-names>L</given-names></name> <name><surname>Levi-Montalcini</surname> <given-names>R</given-names></name></person-group>. <article-title>Mast cells increase in tissues of neonatal rats injected with the nerve growth factor</article-title>. <source>Brain Res</source> (<year>1977</year>) <volume>133</volume>(<issue>2</issue>):<fpage>358</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1016/0006-8993(77)90772-7</pub-id></citation></ref>
<ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsythe</surname> <given-names>P</given-names></name> <name><surname>Bienenstock</surname> <given-names>J</given-names></name></person-group>. <article-title>The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses</article-title>. <source>Chem Immunol Allergy</source> (<year>2012</year>) <volume>98</volume>:<fpage>196</fpage>&#x02013;<lpage>221</lpage>.<pub-id pub-id-type="doi">10.1159/000336523</pub-id><pub-id pub-id-type="pmid">22767065</pub-id></citation></ref>
<ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname> <given-names>J</given-names></name> <name><surname>Aihara</surname> <given-names>M</given-names></name> <name><surname>Kobayashi</surname> <given-names>Y</given-names></name> <name><surname>Kambara</surname> <given-names>T</given-names></name> <name><surname>Ikezawa</surname> <given-names>Z</given-names></name></person-group>. <article-title>Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis</article-title>. <source>J Dermatol Sci</source> (<year>2009</year>) <volume>53</volume>(<issue>1</issue>):<fpage>48</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/j.jdermsci.2008.08.011</pub-id><pub-id pub-id-type="pmid">18922683</pub-id></citation></ref>
<ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quarcoo</surname> <given-names>D</given-names></name> <name><surname>Fischer</surname> <given-names>TC</given-names></name> <name><surname>Peckenschneider</surname> <given-names>N</given-names></name> <name><surname>Groneberg</surname> <given-names>DA</given-names></name> <name><surname>Welker</surname> <given-names>P</given-names></name></person-group>. <article-title>High abundances of neurotrophin 3 in atopic dermatitis mast cell</article-title>. <source>J Occup Med Toxicol</source> (<year>2009</year>) <volume>4</volume>(<issue>8</issue>):<fpage>1</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1186/1745-6673-4-8</pub-id><pub-id pub-id-type="pmid">19386090</pub-id></citation></ref>
<ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>TC</given-names></name> <name><surname>Lauenstein</surname> <given-names>HD</given-names></name> <name><surname>Serowka</surname> <given-names>F</given-names></name> <name><surname>Pilzner</surname> <given-names>C</given-names></name> <name><surname>Groneberg</surname> <given-names>DA</given-names></name> <name><surname>Welker</surname> <given-names>P</given-names></name></person-group>. <article-title>Pan-neurotrophin receptor p75NTR expression is strongly induced in lesional atopic mast cells</article-title>. <source>Clin Exp Allergy</source> (<year>2008</year>) <volume>38</volume>(<issue>7</issue>):<fpage>1168</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2222.2008.02994.x</pub-id><pub-id pub-id-type="pmid">18477014</pub-id></citation></ref>
<ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname> <given-names>EM</given-names></name> <name><surname>Hendrix</surname> <given-names>S</given-names></name> <name><surname>G&#x000F6;lz</surname> <given-names>G</given-names></name> <name><surname>Klapp</surname> <given-names>BF</given-names></name> <name><surname>Arck</surname> <given-names>PC</given-names></name> <name><surname>Paus</surname> <given-names>R</given-names></name></person-group>. <article-title>Nerve growth factor and its precursor differentially regulate hair cycle progression in mice</article-title>. <source>J Histochem Cytochem</source> (<year>2006</year>) <volume>54</volume>(<issue>3</issue>):<fpage>275</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1369/jhc.4A6585.2005</pub-id></citation></ref>
<ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Botchkareva</surname> <given-names>NV</given-names></name> <name><surname>Botchkarev</surname> <given-names>VA</given-names></name> <name><surname>Albers</surname> <given-names>KM</given-names></name> <name><surname>Metz</surname> <given-names>M</given-names></name> <name><surname>Paus</surname> <given-names>R</given-names></name></person-group>. <article-title>Distinct roles for nerve growth factor and brain-derived neurotrophic factor in controlling the rate of hair follicle morphogenesis</article-title>. <source>J Invest Dermatol</source> (<year>2000</year>) <volume>114</volume>(<issue>2</issue>):<fpage>314</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1046/j.1523-1747.2000.00864.x</pub-id><pub-id pub-id-type="pmid">10651992</pub-id></citation></ref>
<ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname> <given-names>EM</given-names></name> <name><surname>Hansen</surname> <given-names>MG</given-names></name> <name><surname>Overall</surname> <given-names>RW</given-names></name> <name><surname>Nakamura</surname> <given-names>M</given-names></name> <name><surname>Pertile</surname> <given-names>P</given-names></name> <name><surname>Klapp</surname> <given-names>BF</given-names></name> <etal/></person-group> <article-title>Control of human hair growth by neurotrophins: brain-derived neurotrophic factor inhibits hair shaft elongation, induces catagen, and stimulates follicular transforming growth factor beta2 expression</article-title>. <source>J Invest Dermatol</source> (<year>2005</year>) <volume>124</volume>(<issue>4</issue>):<fpage>675</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1111/j.0022-202X.2005.23648.x</pub-id><pub-id pub-id-type="pmid">15816823</pub-id></citation></ref>
<ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adly</surname> <given-names>MA</given-names></name> <name><surname>Assaf</surname> <given-names>HA</given-names></name> <name><surname>Nada</surname> <given-names>EA</given-names></name> <name><surname>Soliman</surname> <given-names>M</given-names></name> <name><surname>Hussein</surname> <given-names>M</given-names></name></person-group>. <article-title>Expression of nerve growth factor and its high-affinity receptor, tyrosine kinase A proteins, in the human scalp skin</article-title>. <source>J Cutan Pathol</source> (<year>2006</year>) <volume>33</volume>(<issue>8</issue>):<fpage>559</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1111/j.1600-0560.2006.00443.x</pub-id></citation></ref>
<ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Botchkarev</surname> <given-names>VA</given-names></name> <name><surname>Botchkareva</surname> <given-names>NV</given-names></name> <name><surname>Peters</surname> <given-names>EM</given-names></name> <name><surname>Paus</surname> <given-names>R</given-names></name></person-group>. <article-title>Epithelial growth control by neurotrophins: leads and lessons from the hair follicle</article-title>. <source>Prog Brain Res</source> (<year>2004</year>) <volume>146</volume>:<fpage>493</fpage>&#x02013;<lpage>513</lpage>.<pub-id pub-id-type="doi">10.1016/S0079-6123(03)46031-7</pub-id><pub-id pub-id-type="pmid">14699982</pub-id></citation></ref>
<ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adly</surname> <given-names>MA</given-names></name> <name><surname>Assaf</surname> <given-names>HA</given-names></name> <name><surname>Hussein</surname> <given-names>MR</given-names></name></person-group>. <article-title>Expression pattern of p75 neurotrophin receptor protein in human scalp skin and hair follicles: hair cycle-dependent expression</article-title>. <source>J Am Acad Dermatol</source> (<year>2009</year>) <volume>60</volume>(<issue>1</issue>):<fpage>99</fpage>&#x02013;<lpage>109</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaad.2008.09.060</pub-id><pub-id pub-id-type="pmid">19103362</pub-id></citation></ref>
<ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname> <given-names>EM</given-names></name> <name><surname>Stieglitz</surname> <given-names>MG</given-names></name> <name><surname>Liezman</surname> <given-names>C</given-names></name> <name><surname>Overall</surname> <given-names>RW</given-names></name> <name><surname>Nakamura</surname> <given-names>M</given-names></name> <name><surname>Hagen</surname> <given-names>E</given-names></name> <etal/></person-group> <article-title>p75 neurotrophin receptor-mediated signaling promotes human hair follicle regression (catagen)</article-title>. <source>Am J Pathol</source> (<year>2006</year>) <volume>168</volume>(<issue>1</issue>):<fpage>221</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.2353/ajpath.2006.050163</pub-id></citation></ref>
<ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livshits</surname> <given-names>G</given-names></name> <name><surname>Kobielak</surname> <given-names>A</given-names></name> <name><surname>Fuchs</surname> <given-names>E</given-names></name></person-group>. <article-title>Governing epidermal homeostasis by coupling cell-cell adhesion to integrin and growth factor signaling, proliferation, and apoptosis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2012</year>) <volume>109</volume>:<fpage>4886</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1202120109</pub-id><pub-id pub-id-type="pmid">22411810</pub-id></citation></ref>
<ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pincelli</surname> <given-names>C</given-names></name> <name><surname>Marconi</surname> <given-names>A</given-names></name></person-group>. <article-title>Keratinocyte stem cells: friends and foes</article-title>. <source>J Cell Physiol</source> (<year>2010</year>) <volume>225</volume>(<issue>2</issue>):<fpage>310</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1002/jcp.22275</pub-id><pub-id pub-id-type="pmid">20568222</pub-id></citation></ref>
<ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname> <given-names>P</given-names></name></person-group>. <article-title>Interfollicular epidermal stem cells: identification, challenges, potential</article-title>. <source>J Invest Dermatol</source> (<year>2006</year>) <volume>126</volume>(<issue>7</issue>):<fpage>1450</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/sj.jid.5700184</pub-id><pub-id pub-id-type="pmid">16543901</pub-id></citation></ref>
<ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname> <given-names>E</given-names></name> <name><surname>Doup&#x000E9;</surname> <given-names>DP</given-names></name> <name><surname>Klein</surname> <given-names>AM</given-names></name> <name><surname>Winton</surname> <given-names>DJ</given-names></name> <name><surname>Simons</surname> <given-names>BD</given-names></name> <name><surname>Jones</surname> <given-names>PH</given-names></name></person-group>. <article-title>A single type of progenitor cell maintains normal epidermis</article-title>. <source>Nature</source> (<year>2007</year>) <volume>446</volume>:<fpage>185</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nature05574</pub-id></citation></ref>
<ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sada</surname> <given-names>A</given-names></name> <name><surname>Jacob</surname> <given-names>F</given-names></name> <name><surname>Leung</surname> <given-names>E</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>White</surname> <given-names>BS</given-names></name> <name><surname>Shalloway</surname> <given-names>D</given-names></name> <etal/></person-group> <article-title>Defining the cellular lineage hierarchy in the interfollicular epidermis of adult skin</article-title>. <source>Nat Cell Biol</source> (<year>2016</year>) <volume>18</volume>(<issue>6</issue>):<fpage>619</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1038/ncb3359</pub-id><pub-id pub-id-type="pmid">27183471</pub-id></citation></ref>
<ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simonart</surname> <given-names>T</given-names></name> <name><surname>Heenen</surname> <given-names>M</given-names></name> <name><surname>Lejeune</surname> <given-names>O</given-names></name></person-group>. <article-title>Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal</article-title>. <source>Cell Prolif</source> (<year>2010</year>) <volume>43</volume>(<issue>3</issue>):<fpage>321</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2184.2010.00672.x</pub-id><pub-id pub-id-type="pmid">20546247</pub-id></citation></ref>
<ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pincelli</surname> <given-names>C</given-names></name></person-group>. <article-title>Nerve growth factor and keratinocytes: a role in psoriasis</article-title>. <source>Eur J Dermatol</source> (<year>2000</year>) <volume>10</volume>(<issue>2</issue>):<fpage>85</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">10694304</pub-id></citation></ref>
<ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Truzzi</surname> <given-names>F</given-names></name> <name><surname>Marconi</surname> <given-names>A</given-names></name> <name><surname>Atzei</surname> <given-names>P</given-names></name> <name><surname>Panza</surname> <given-names>MC</given-names></name> <name><surname>Lotti</surname> <given-names>R</given-names></name> <name><surname>Dallaglio</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>p75 neurotrophin receptor mediates apoptosis in transit-amplifying cells and its overexpression restores cell death in psoriatic keratinocytes</article-title>. <source>Cell Death Differ</source> (<year>2011</year>) <volume>18</volume>(<issue>6</issue>):<fpage>948</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1038/cdd.2010.162</pub-id><pub-id pub-id-type="pmid">21151024</pub-id></citation></ref>
<ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fantini</surname> <given-names>F</given-names></name> <name><surname>Magnoni</surname> <given-names>C</given-names></name> <name><surname>Bracci-Laudiero</surname> <given-names>L</given-names></name> <name><surname>Pincelli</surname> <given-names>C</given-names></name></person-group>. <article-title>Nerve growth factor is increased in psoriatic skin</article-title>. <source>J Invest Dermatol</source> (<year>1995</year>) <volume>105</volume>(<issue>6</issue>):<fpage>854</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1111/1523-1747.ep12326689</pub-id></citation></ref>
<ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raychaudhuri</surname> <given-names>SP</given-names></name> <name><surname>Jiang</surname> <given-names>WY</given-names></name> <name><surname>Farber</surname> <given-names>EM</given-names></name></person-group>. <article-title>Psoriatic keratinocytes express high levels of nerve growth factor</article-title>. <source>Acta Derm Venereol</source> (<year>1998</year>) <volume>78</volume>(<issue>2</issue>):<fpage>84</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1080/000155598433368</pub-id><pub-id pub-id-type="pmid">9534881</pub-id></citation></ref>
<ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ceni</surname> <given-names>C</given-names></name> <name><surname>Unsain</surname> <given-names>N</given-names></name> <name><surname>Zeinieh</surname> <given-names>MP</given-names></name> <name><surname>Barker</surname> <given-names>PA</given-names></name></person-group>. <article-title>Neurotrophins in the regulation of cellular survival and death</article-title>. <source>Handb Exp Pharmacol</source> (<year>2014</year>) <volume>220</volume>:<fpage>193</fpage>&#x02013;<lpage>221</lpage>.<pub-id pub-id-type="doi">10.1007/978-3-642-45106-5_8</pub-id><pub-id pub-id-type="pmid">24668474</pub-id></citation></ref>
<ref id="B61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marconi</surname> <given-names>A</given-names></name> <name><surname>Vaschieri</surname> <given-names>C</given-names></name> <name><surname>Zanoli</surname> <given-names>S</given-names></name> <name><surname>Giannetti</surname> <given-names>A</given-names></name> <name><surname>Pincelli</surname> <given-names>C</given-names></name></person-group>. <article-title>Nerve growth factor protects human keratinocytes from ultraviolet-B-induced apoptosis</article-title>. <source>J Invest Dermatol</source> (<year>1999</year>) <volume>113</volume>(<issue>6</issue>):<fpage>920</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1046/j.1523-1747.1999.00773.x</pub-id><pub-id pub-id-type="pmid">10594731</pub-id></citation></ref>
<ref id="B62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pincelli</surname> <given-names>C</given-names></name> <name><surname>Marconi</surname> <given-names>A</given-names></name></person-group>. <article-title>Autocrine nerve growth factor in human keratinocytes</article-title>. <source>J Dermatol Sci</source> (<year>2000</year>) <volume>22</volume>(<issue>2</issue>):<fpage>71</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/S0923-1811(99)00065-1</pub-id><pub-id pub-id-type="pmid">10674819</pub-id></citation></ref>
<ref id="B63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raychaudhuri</surname> <given-names>SP</given-names></name> <name><surname>Jiang</surname> <given-names>WY</given-names></name> <name><surname>Raychaudhuri</surname> <given-names>SK</given-names></name></person-group>. <article-title>Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis</article-title>. <source>Am J Pathol</source> (<year>2008</year>) <volume>172</volume>(<issue>4</issue>):<fpage>961</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.2353/ajpath.2008.070710</pub-id><pub-id pub-id-type="pmid">18349121</pub-id></citation></ref>
<ref id="B64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raychaudhuri</surname> <given-names>SP</given-names></name> <name><surname>Sanyal</surname> <given-names>M</given-names></name> <name><surname>Weltman</surname> <given-names>H</given-names></name> <name><surname>Kundu-Raychaudhuri</surname> <given-names>S</given-names></name></person-group>. <article-title>K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model</article-title>. <source>J Invest Dermatol</source> (<year>2004</year>) <volume>122</volume>(<issue>3</issue>):<fpage>812</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.0022-202X.2003.12602.x</pub-id></citation></ref>
<ref id="B65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laporte</surname> <given-names>M</given-names></name> <name><surname>Galand</surname> <given-names>P</given-names></name> <name><surname>Fokan</surname> <given-names>D</given-names></name> <name><surname>de Graef</surname> <given-names>C</given-names></name> <name><surname>Heenen</surname> <given-names>M</given-names></name></person-group>. <article-title>Apoptosis in established and healing psoriasis</article-title>. <source>Dermatology</source> (<year>2000</year>) <volume>200</volume>(<issue>4</issue>):<fpage>314</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1159/000018394</pub-id><pub-id pub-id-type="pmid">10894962</pub-id></citation></ref>
<ref id="B66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wrone-Smith</surname> <given-names>T</given-names></name> <name><surname>Mitra</surname> <given-names>RS</given-names></name> <name><surname>Thompson</surname> <given-names>CB</given-names></name> <name><surname>Jasty</surname> <given-names>R</given-names></name> <name><surname>Castle</surname> <given-names>VP</given-names></name> <name><surname>Nickoloff</surname> <given-names>BJ</given-names></name></person-group>. <article-title>Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin</article-title>. <source>Am J Pathol</source> (<year>1997</year>) <volume>151</volume>(<issue>5</issue>):<fpage>1321</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">9358758</pub-id></citation></ref>
<ref id="B67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>X</given-names></name> <name><surname>Zhao</surname> <given-names>J</given-names></name> <name><surname>Wu</surname> <given-names>X</given-names></name> <name><surname>Shi</surname> <given-names>H</given-names></name> <name><surname>Liu</surname> <given-names>W</given-names></name> <name><surname>Cui</surname> <given-names>B</given-names></name> <etal/></person-group> <article-title>PageRank analysis reveals topologically expressed genes correspond to psoriasis and their functions are associated with apoptosis resistance</article-title>. <source>Mol Med Rep</source> (<year>2016</year>) <volume>13</volume>(<issue>5</issue>):<fpage>3969</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.3892/mmr.2016.4999</pub-id><pub-id pub-id-type="pmid">27035208</pub-id></citation></ref>
<ref id="B68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaar</surname> <given-names>M</given-names></name> <name><surname>Zhai</surname> <given-names>S</given-names></name> <name><surname>Pilch</surname> <given-names>PF</given-names></name> <name><surname>Doyle</surname> <given-names>SM</given-names></name> <name><surname>Eisenhauer</surname> <given-names>PB</given-names></name> <name><surname>Fine</surname> <given-names>RE</given-names></name> <etal/></person-group> <article-title>Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer&#x02019;s disease</article-title>. <source>J Clin Invest</source> (<year>1997</year>) <volume>100</volume>:<fpage>2333</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1172/JCI119772</pub-id></citation></ref>
<ref id="B69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname> <given-names>MV</given-names></name> <name><surname>Bothwell</surname> <given-names>M</given-names></name></person-group>. <article-title>Neurotrophins: to cleave or not to cleave</article-title>. <source>Neuron</source> (<year>2002</year>) <volume>33</volume>:<fpage>9</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/S0896-6273(01)00573-6</pub-id><pub-id pub-id-type="pmid">11779474</pub-id></citation></ref>
<ref id="B70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kashiwai</surname> <given-names>K</given-names></name> <name><surname>Kajiya</surname> <given-names>M</given-names></name> <name><surname>Matsuda</surname> <given-names>S</given-names></name> <name><surname>Ouhara</surname> <given-names>K</given-names></name> <name><surname>Takeda</surname> <given-names>K</given-names></name> <name><surname>Takata</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>Distinction between cell proliferation and apoptosis signals regulated by brain-derived neurotrophic factor in human periodontal ligament cells and gingival epithelial cells</article-title>. <source>J Cell Biochem</source> (<year>2016</year>) <volume>117</volume>(<issue>7</issue>):<fpage>1543</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1002/jcb.25446</pub-id><pub-id pub-id-type="pmid">26581032</pub-id></citation></ref>
<ref id="B71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khwaja</surname> <given-names>FS</given-names></name> <name><surname>Quann</surname> <given-names>EJ</given-names></name> <name><surname>Pattabiraman</surname> <given-names>N</given-names></name> <name><surname>Wynne</surname> <given-names>S</given-names></name> <name><surname>Djakiew</surname> <given-names>D</given-names></name></person-group>. <article-title>Carprofen induction of p75NTR-dependent apoptosis via the p38 mitogen-activated protein kinase pathway in prostate cancer cells</article-title>. <source>Mol Cancer Ther</source> (<year>2008</year>) <volume>7</volume>(<issue>11</issue>):<fpage>3539</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1158/1535-7163.MCT-08-0512</pub-id><pub-id pub-id-type="pmid">18974393</pub-id></citation></ref>
<ref id="B72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salehi</surname> <given-names>AH</given-names></name> <name><surname>Xanthoudakis</surname> <given-names>S</given-names></name> <name><surname>Barker</surname> <given-names>PA</given-names></name></person-group>. <article-title>NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway</article-title>. <source>J Biol Chem</source> (<year>2002</year>) <volume>277</volume>:<fpage>48043</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M205324200</pub-id></citation></ref>
<ref id="B73"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Truzzi</surname> <given-names>F</given-names></name> <name><surname>Saltari</surname> <given-names>A</given-names></name> <name><surname>Palazzo</surname> <given-names>E</given-names></name> <name><surname>Lotti</surname> <given-names>R</given-names></name> <name><surname>Petrachi</surname> <given-names>T</given-names></name> <name><surname>Dallaglio</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>CD271 mediates stem cells to early progeny transition in human epidermis</article-title>. <source>J Invest Dermatol</source> (<year>2015</year>) <volume>135</volume>(<issue>3</issue>):<fpage>786</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1038/jid.2014.454</pub-id><pub-id pub-id-type="pmid">25330297</pub-id></citation></ref>
<ref id="B74"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guti&#x000E9;rrez-Rivera</surname> <given-names>A</given-names></name> <name><surname>Pav&#x000F3;n-Rodr&#x000ED;guez</surname> <given-names>A</given-names></name> <name><surname>Jim&#x000E9;nez-Acosta</surname> <given-names>F</given-names></name> <name><surname>Poblet</surname> <given-names>E</given-names></name> <name><surname>Braun</surname> <given-names>KM</given-names></name> <name><surname>Cormenzana</surname> <given-names>P</given-names></name> <etal/></person-group> <article-title>Functional characterization of highly adherent CD34&#x0002B; keratinocytes isolated from human skin</article-title>. <source>Exp Dermatol</source> (<year>2010</year>) <volume>19</volume>(<issue>7</issue>):<fpage>685</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1600-0625.2010.01075.x</pub-id><pub-id pub-id-type="pmid">20500767</pub-id></citation></ref>
<ref id="B75"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>A</given-names></name> <name><surname>Pouliot</surname> <given-names>N</given-names></name> <name><surname>Redvers</surname> <given-names>R</given-names></name> <name><surname>Kaur</surname> <given-names>P</given-names></name></person-group>. <article-title>Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny</article-title>. <source>J Clin Invest</source> (<year>2004</year>) <volume>113</volume>(<issue>3</issue>):<fpage>390</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="doi">10.1172/JCI19140</pub-id><pub-id pub-id-type="pmid">14755336</pub-id></citation></ref>
<ref id="B76"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schl&#x000FC;ter</surname> <given-names>H</given-names></name> <name><surname>Kaur</surname> <given-names>P</given-names></name></person-group>. <article-title>In vivo transplantation assay at limiting dilution to identify the intrinsic tissue reconstitutive capacity of keratinocyte stem cells and their progeny</article-title>. <source>Methods Mol Biol</source> (<year>2013</year>) <volume>989</volume>:<fpage>165</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1007/978-1-62703-330-5_14</pub-id><pub-id pub-id-type="pmid">23483395</pub-id></citation></ref>
<ref id="B77"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>HY</given-names></name> <name><surname>Shi</surname> <given-names>Y</given-names></name> <name><surname>Luo</surname> <given-names>LF</given-names></name> <name><surname>Jiang</surname> <given-names>G</given-names></name> <name><surname>Zhou</surname> <given-names>Q</given-names></name> <name><surname>Xu</surname> <given-names>SZ</given-names></name> <etal/></person-group> <article-title>Asymmetric stem-cell division ensures sustained keratinocyte hyperproliferation in psoriatic skin lesions</article-title>. <source>Int J Mol Med</source> (<year>2016</year>) <volume>37</volume>(<issue>2</issue>):<fpage>359</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.3892/ijmm.2015.2445</pub-id><pub-id pub-id-type="pmid">26707630</pub-id></citation></ref>
<ref id="B78"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castelijns</surname> <given-names>FA</given-names></name> <name><surname>Gerritsen</surname> <given-names>MJ</given-names></name> <name><surname>van Erp</surname> <given-names>PE</given-names></name> <name><surname>van de Kerkhof</surname> <given-names>PC</given-names></name></person-group>. <article-title>Cell-kinetic evidence for increased recruitment of cycling epidermal cells in psoriasis: the ratio of histone and Ki-67 antigen expression is constant</article-title>. <source>Dermatology</source> (<year>2000</year>) <volume>201</volume>(<issue>2</issue>):<fpage>105</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1159/000018471</pub-id><pub-id pub-id-type="pmid">11053911</pub-id></citation></ref>
<ref id="B79"><label>79</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grabe</surname> <given-names>N</given-names></name> <name><surname>Neuber</surname> <given-names>K</given-names></name></person-group>. <article-title>Simulating psoriasis by altering transit amplifying cells</article-title>. <source>Bioinformatics</source> (<year>2007</year>) <volume>23</volume>(<issue>11</issue>):<fpage>1309</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1093/bioinformatics/btm042</pub-id><pub-id pub-id-type="pmid">17308343</pub-id></citation></ref>
<ref id="B80"><label>80</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franssen</surname> <given-names>ME</given-names></name> <name><surname>Zeeuwen</surname> <given-names>PL</given-names></name> <name><surname>Vierwinden</surname> <given-names>G</given-names></name> <name><surname>van de Kerkhof</surname> <given-names>PC</given-names></name> <name><surname>Schalkwijk</surname> <given-names>J</given-names></name> <name><surname>van Erp</surname> <given-names>PE</given-names></name></person-group>. <article-title>Phenotypical and functional differences in germinative subpopulations derived from normal and psoriatic epidermis</article-title>. <source>J Invest Dermatol</source> (<year>2005</year>) <volume>124</volume>(<issue>2</issue>):<fpage>373</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1111/j.0022-202X.2004.23612.x</pub-id><pub-id pub-id-type="pmid">15675957</pub-id></citation></ref>
<ref id="B81"><label>81</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lippens</surname> <given-names>S</given-names></name> <name><surname>Kockx</surname> <given-names>M</given-names></name> <name><surname>Knaapen</surname> <given-names>M</given-names></name> <name><surname>Mortier</surname> <given-names>L</given-names></name> <name><surname>Polakowska</surname> <given-names>R</given-names></name> <name><surname>Verheyen</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing</article-title>. <source>Cell Death Differ</source> (<year>2000</year>) <volume>7</volume>(<issue>12</issue>):<fpage>1218</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1038/sj.cdd.4400785</pub-id><pub-id pub-id-type="pmid">11175259</pub-id></citation></ref>
<ref id="B82"><label>82</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Truzzi</surname> <given-names>F</given-names></name> <name><surname>Marconi</surname> <given-names>A</given-names></name> <name><surname>Lotti</surname> <given-names>R</given-names></name> <name><surname>Dallaglio</surname> <given-names>K</given-names></name> <name><surname>French</surname> <given-names>LE</given-names></name> <name><surname>Hempstead</surname> <given-names>BL</given-names></name> <etal/></person-group> <article-title>Neurotrophins and their receptors stimulate melanoma cell proliferation and migration</article-title>. <source>J Invest Dermatol</source> (<year>2008</year>) <volume>128</volume>(<issue>8</issue>):<fpage>2031</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1038/jid.2008.21</pub-id></citation></ref>
<ref id="B83"><label>83</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ord&#x000F3;&#x000F1;ez</surname> <given-names>NG</given-names></name></person-group>. <article-title>Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update</article-title>. <source>Hum Pathol</source> (<year>2014</year>) <volume>45</volume>(<issue>2</issue>):<fpage>191</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="doi">10.1016/j.humpath.2013.02.007</pub-id><pub-id pub-id-type="pmid">23648379</pub-id></citation></ref>
<ref id="B84"><label>84</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>DD</given-names></name> <name><surname>Emley</surname> <given-names>A</given-names></name> <name><surname>Yang</surname> <given-names>S</given-names></name> <name><surname>Richards</surname> <given-names>JE</given-names></name> <name><surname>Lee</surname> <given-names>JE</given-names></name> <name><surname>Deng</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal</article-title>. <source>Mod Pathol</source> (<year>2012</year>) <volume>25</volume>(<issue>4</issue>):<fpage>505</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1038/modpathol.2011.196</pub-id><pub-id pub-id-type="pmid">22157936</pub-id></citation></ref>
<ref id="B85"><label>85</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sigal</surname> <given-names>AC</given-names></name> <name><surname>Keenan</surname> <given-names>M</given-names></name> <name><surname>Lazova</surname> <given-names>R</given-names></name></person-group>. <article-title>p75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin</article-title>. <source>Am J Dermatopathol</source> (<year>2012</year>) <volume>34</volume>:<fpage>145</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1097/DAD.0b013e318225b596</pub-id><pub-id pub-id-type="pmid">22207443</pub-id></citation></ref>
<ref id="B86"><label>86</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alamodi</surname> <given-names>AA</given-names></name> <name><surname>Eshaq</surname> <given-names>AM</given-names></name> <name><surname>Hassan</surname> <given-names>SY</given-names></name> <name><surname>Al Hmada</surname> <given-names>Y</given-names></name> <name><surname>El Jamal</surname> <given-names>SM</given-names></name> <name><surname>Fothan</surname> <given-names>AM</given-names></name> <etal/></person-group> <article-title>Cancer stem cell as therapeutic target for melanoma treatment</article-title>. <source>Histol Histopathol</source> (<year>2016</year>) <volume>31</volume>(<issue>12</issue>):<fpage>1291</fpage>&#x02013;<lpage>301</lpage>.<pub-id pub-id-type="doi">10.14670/HH-11-791</pub-id><pub-id pub-id-type="pmid">27301538</pub-id></citation></ref>
<ref id="B87"><label>87</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname> <given-names>EK</given-names></name> <name><surname>Jordan</surname> <given-names>SA</given-names></name> <name><surname>Oshima</surname> <given-names>H</given-names></name> <name><surname>Yoshida</surname> <given-names>H</given-names></name> <name><surname>Osawa</surname> <given-names>M</given-names></name> <name><surname>Moriyama</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Dominant role of the niche in melanocyte stem-cell fate determination</article-title>. <source>Nature</source> (<year>2002</year>) <volume>416</volume>(<issue>6883</issue>):<fpage>854</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1038/416854a</pub-id><pub-id pub-id-type="pmid">11976685</pub-id></citation></ref>
<ref id="B88"><label>88</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shakhova</surname> <given-names>O</given-names></name></person-group>. <article-title>Neural crest stem cells in melanoma development</article-title>. <source>Curr Opin Oncol</source> (<year>2014</year>) <volume>26</volume>(<issue>2</issue>):<fpage>215</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1097/CCO.0000000000000046</pub-id><pub-id pub-id-type="pmid">24441506</pub-id></citation></ref>
<ref id="B89"><label>89</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boiko</surname> <given-names>AD</given-names></name> <name><surname>Razorenova</surname> <given-names>OV</given-names></name> <name><surname>van de Rijn</surname> <given-names>M</given-names></name> <name><surname>Swetter</surname> <given-names>SM</given-names></name> <name><surname>Johnson</surname> <given-names>DL</given-names></name> <name><surname>Ly</surname> <given-names>DP</given-names></name> <etal/></person-group> <article-title>Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>(<issue>7302</issue>):<fpage>133</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature09161</pub-id><pub-id pub-id-type="pmid">20596026</pub-id></citation></ref>
<ref id="B90"><label>90</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quintana</surname> <given-names>E</given-names></name> <name><surname>Shackleton</surname> <given-names>M</given-names></name> <name><surname>Foster</surname> <given-names>HR</given-names></name> <name><surname>Fullen</surname> <given-names>DR</given-names></name> <name><surname>Sabel</surname> <given-names>MS</given-names></name> <name><surname>Johnson</surname> <given-names>TM</given-names></name> <etal/></person-group> <article-title>Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized</article-title>. <source>Cancer Cell</source> (<year>2010</year>)&#x02009;<volume>18</volume>(<issue>5</issue>):<fpage>510</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/j.ccr.2010.10.012</pub-id><pub-id pub-id-type="pmid">21075313</pub-id></citation></ref>
<ref id="B91"><label>91</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname> <given-names>SE</given-names></name> <name><surname>Fedele</surname> <given-names>CG</given-names></name> <name><surname>Corbin</surname> <given-names>V</given-names></name> <name><surname>Wybacz</surname> <given-names>E</given-names></name> <name><surname>Szeto</surname> <given-names>P</given-names></name> <name><surname>Lewin</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>CD271 expression on patient melanoma cells is unstable and unlinked to tumorigenicity</article-title>. <source>Cancer Res</source> (<year>2016</year>) <volume>76</volume>(<issue>13</issue>):<fpage>3965</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-2377</pub-id><pub-id pub-id-type="pmid">27325642</pub-id></citation></ref>
<ref id="B92"><label>92</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marconi</surname> <given-names>A</given-names></name> <name><surname>Borroni</surname> <given-names>RG</given-names></name> <name><surname>Truzzi</surname> <given-names>F</given-names></name> <name><surname>Longo</surname> <given-names>C</given-names></name> <name><surname>Pistoni</surname> <given-names>F</given-names></name> <name><surname>Pellacani</surname> <given-names>G</given-names></name> <etal/></person-group> <article-title>Hypoxia-inducible factor-1&#x003B1; and CD271 inversely correlate with melanoma invasiveness</article-title>. <source>Exp Dermatol</source> (<year>2015</year>) <volume>24</volume>(<issue>5</issue>):<fpage>396</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/exd.12679</pub-id><pub-id pub-id-type="pmid">25739328</pub-id></citation></ref>
<ref id="B93"><label>93</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saltari</surname> <given-names>A</given-names></name> <name><surname>Truzzi</surname> <given-names>F</given-names></name> <name><surname>Quadri</surname> <given-names>M</given-names></name> <name><surname>Lotti</surname> <given-names>R</given-names></name> <name><surname>Palazzo</surname> <given-names>E</given-names></name> <name><surname>Grisendi</surname> <given-names>G</given-names></name> <etal/></person-group> <article-title>CD271 down-regulation promotes melanoma progression and invasion in three-dimensional models and in zebrafish</article-title>. <source>J Invest Dermatol</source> (<year>2016</year>) <volume>136</volume>(<issue>10</issue>):<fpage>2049</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1016/j.jid.2016.05.116</pub-id><pub-id pub-id-type="pmid">27328305</pub-id></citation></ref>
<ref id="B94"><label>94</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selimovic</surname> <given-names>D</given-names></name> <name><surname>Sprenger</surname> <given-names>A</given-names></name> <name><surname>Hannig</surname> <given-names>M</given-names></name> <name><surname>Ha&#x000EF;kel</surname> <given-names>Y</given-names></name> <name><surname>Hassan</surname> <given-names>M</given-names></name></person-group>. <article-title>Apoptosis related protein-1 triggers melanoma cell death via interaction with the juxtamembrane region of p75 neurotrophin receptor</article-title>. <source>J Cell Mol Med</source> (<year>2012</year>) <volume>16</volume>(<issue>2</issue>):<fpage>349</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01304.x</pub-id><pub-id pub-id-type="pmid">21418516</pub-id></citation></ref>
</ref-list>
</back>
</article>
